Research on the menopause

Maturitas

Volumn 23, Issue 2, 1996, Pages 109-112

  Hulka, Barbara S ^a   Meirik, Olav ^b  

^a IL   (United States)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

HORMONE;

ADULT; CARDIOVASCULAR DISEASE; CONFERENCE PAPER; FEMALE; HORMONE SUBSTITUTION; HUMAN; MENOPAUSE; OSTEOPOROSIS; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; WORLD HEALTH ORGANIZATION;

EID: 0029941254     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-5122(95)00967-1     Document Type: Conference Paper

References (17)

1. WHO Technical Report Series. Research on the menopause in the 1990's. In press, 1995.
2. World Bank. World Development Report 1993: Investing in health. New York: Oxford University Press, 1993.
3. Kaufert PA. The social and cultural context of menopause. Maturitas, in press, 1995.
4. Oldenhave A, Jaszmann LJB. The climacteric: absence of presence of hot flushes and their relation to other complaints. In: Schonbaum E, ed. The Climacteric Hot Flush. Prog Basic Clin Pharmacol. Basel: Karger 1991; 6: 1-39.
5. van Hall EV, Verdel M, van der Veldon J. Perimenopausal complaints in women and men: a comparative study. J Womens Health 1994; 3: 45-49.
6. Dennerstein L. Well-Being, Symptoms and the menopausal transition. Maturitas, in press, 1995.
7. McKinlay SM. Issues in design, measurement, and analysis for menopause research. Exp Gerontol 1994; 29: 479-493.
8. Kennedy DL, Baum C, Forbes MB. Noncontraceptive estrogens and progestins: use patterns over time. Obstet Gynecol 1985; 65: 441-446.
9. Weiss NS, Hill DA. Postmenopausal estrogens and progestogens and the incidence of gynecologic cancer. Maturitas, in press, 1995.
10. Colditz GA, Hankinson SE, Hunter DJ, Willett WC, Manson JE, Stampfer MJ, Hennekens C, Rosner B, Speizer FE. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. New Engl J Med 1995; 332(24): 1589-1593.
11. Grady D, Rubin SM, Petitti DB, Fox CS, Black D, Ettinger B, Ernster VL, Cummings SR. Hormone therapy to prevent disease and prolong life in postmenopausal women. Annals Intern Med 1992; 117(12): 1016-1041.
12. Dalv E, Vessev MP, Barlow D. Gray A, McPherson K, Roche M. Hormone replacement therapy in a risk-benefit perspective. Maturitas, in press, 1995.
13. The Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) trial. J Am Med Assoc 1995; 273(3): 199-208.
14. Greenwald P, Kelloff G, Burch-Whitman C, Kramer BS. Chemoprevention. CA-A Cancer J Clin 1995; 45: 31-49.
15. Barrett-Connor E. The menopause, hormone replacement, and cardiovascular disease: the epidemiologic evidence. Maturitas, in press, 1995.
16. Wark JD. Osteoporotic fractures: background and prevention strategies. Maturitas, in press, 1995.
17. World Health Statistics Annual. Geneva, World Health Organization, 1994.